Editorial Board Member - JAR
GHASSAN M. MATAR
ProfessorDepartment of Experimental Pathology, Immunology & Microbiology
Faculty of Medicine
American University of Beirut
Lebanon
BIOGRAPHY:
Dr. Ghassan M. Matar is presently working as a Professor in the Department of Experimental Pathology, Immunology & Microbiology and Laboratory Director of the Center for Infectious Diseases Research at the Faculty of Medicine, American University of Beirut (AUB), Lebanon. He received his PhD in Basic Medical Sciences (Microbiology) from AUB and was a post-doctoral fellow (Fulbright) at the Centers for Disease Control Prevention (CDC) and Department of Microbiology and Immunology, Emory University in Atlanta, Georgia, USA. He was then appointed as Research Microbiologist at the Division of Bacterial and Mycotic Diseases, CDC. He was also appointed as Assistant Dean at the Faculty of Health Science, AUB. In addition, he serves on Faculty of Medicine (FM) and University wide committees at AUB, in WHO as resource advisor in the Advisory Group on Integrated Surveillance of Antimicrobial Agents (AGISAR), and as American Society for Microbiology (ASM) Ambassador for Lebanon. His Laboratory also has a PulseNet Laboratory certified by CDC/NAMRU3. To present he served as an academic advisor to 40 graduate students, published around 87 articles in reputable refereed international journals and presented 115 abstracts in international, regional and local conferences. He received funding from various extramural sources such as: CDC, U.S. Department of Defense (DOD), WHO/AGISAR, PulseNet (CDC, WHO, MOPH) and others.
RESEARCH INTERESTS:
His research interests include: 1) Molecular mechanisms of resistance to antimicrobial agents in pathogenic bacteria, namely methicillin resistance in S. aureus, macrolide resistance in S. pneumoniae and carbapenem resistance in ESBL and non-ESBL producing Enterobacteriaceae, 2) Potential Treatment with antibacterial agents singly or in combination of E. coli O157:H7 and E. coli O104:H4 infections in a mouse model, 3) Genetic basis of biofilm production in P. aeruginosa isolated from patients with nosocomial infections and potential inhibition of biofilm formation by antifungal agents in in vitro and in vivo studies, 4) Expression levels of virulence factors produced by pathogenic bacterial agents in relation to disease production, 5) Molecular epidemiology of foodborne diseases and nosocomial infections, 6) Assessment of combination therapy in infections caused by carbapenem resistant Enterobacteriaceae harboring various carbapenemase encoding genes, 7) Molecular characterization of Listeria monocyogenes from food items.
Other Editorial Board Members - JAR
UDAI P. SINGH
Department of Pathology, Microbiology and Immunology
University of South Carolina
United States
ELENA A. USACHEVA
Department of Pathology
University of Chicago Pritzker School of Medicine
United States
SALEH A. NASER
Burnett School of Biomedical Sciences
University of Central Florida
United States
JANAK PADIA
Center of Biomolecular Therapeutics
University of Maryland
United States
Suresh G. Joshi
Department of Microbiology and Immunology
Drexel University
United States
BEDENIC BRANKA
Department of Microbiology
School of Medicine
University of Zagreb
Croatia
ASIF ALI
Academy of Scientific & Innovative Research (AcSIR)
India
LUIS CLAUDIO NASCIMENTO DA SILVA
Ceuma University
Rua dos Castanheiros Jardim Renascença 65075120 - São Luís
Brazil
GEORGE DINOS
Department of Biochemistry
University of Patras
Greece
ROBERT TODD STRIKER
Department of Microbiology and Immunology
University of Wisconsin
United States